Marie O'SHea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marie O'SHea has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Christine Tait-Burkard
The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, UK
4 shared publications - Sarah Fletcher
The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom
4 shared publications - Alexandros Hardas
Department of Pathobiology & Population Sciences The Royal Veterinary College, University of London London UK
3 shared publications Antria Zanti
Vet Dia Gnosis Ltd, Limassol, Cyprus
3 shared publications- Maria Lyraki
Section of Small Animal Diseases, Faculty of Veterinary Medicine, The University of Veterinary Sciences Brno, 61242 Brno, Czech Republic
3 shared publications Rachael Hammond
Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (2)
RNA interference screen against SARS-CoV-2 identifies proviral vesicular transport factors involved in release
Identifying host factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to understanding the replication cycle and developing host-targeting antivirals. However, most host factor screens are significantly biassed towards early replication factors and miss the important steps of assembly and release. Here, we present an arrayed, druggable genome RNAi knockdown screen interrogating SARS-CoV-2 replication in human cells using reverse transcription-quantitative polymerase chain reaction quantification of virus production at two timepoints for comprehensive analysis of pro- and antiviral factors across the entire replication and reinfection cycle. Comparative meta-analysis with other screens and genome-wide association studies demonstrated overlap. Pathway analysis and validation confirmed the identification of known and novel key pathways in SARS-CoV-2 infection. A cluster of proviral factors involved in vesicle-mediated exocytic transport was confirmed to be involved in virus production in the ‘European original’ and variants Delta and Omicron. Inhibiting proviral Rab11a-mediated cargo delivery with cyclin-dependent kinase 9 inhibitor-73 prevented SARS-CoV-2 release, highlighting potential new mechanisms of action for host-targeting antivirals.
- 13 February 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (2)
Open AccessRNA interference screen against SARS-CoV-2 identifies proviral vesicular transport factors involved in release
Identifying host factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to understanding the replication cycle and developing host-targeting antivirals. However, most host factor screens are significantly biassed towards early replication factors and miss the important steps of assembly and release. Here, we present an arrayed, druggable genome RNAi knockdown screen interrogating SARS-CoV-2 replication in human cells using reverse transcription-quantitative polymerase chain reaction quantification of virus production at two timepoints for comprehensive analysis of pro- and antiviral factors across the entire replication and reinfection cycle. Comparative meta-analysis with other screens and genome-wide association studies demonstrated overlap. Pathway analysis and validation confirmed the identification of known and novel key pathways in SARS-CoV-2 infection. A cluster of proviral factors involved in vesicle-mediated exocytic transport was confirmed to be involved in virus production in the ‘European original’ and variants Delta and Omicron. Inhibiting proviral Rab11a-mediated cargo delivery with cyclin-dependent kinase 9 inhibitor-73 prevented SARS-CoV-2 release, highlighting potential new mechanisms of action for host-targeting antivirals.
- Top Cited PapersOpen Access
- 9 July 2025
- Published by Springer Nature in Nature
- Vol. 645 (8079) , 228-234
Feline infectious peritonitis epizootic caused by a recombinant coronavirus
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1–3. While the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed4–7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as the susceptibility of these animals to SARS-CoV-29, highlight their importance in potential transmission cycles. While recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a highly pathogenic FCoV–CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP) originating in Cyprus11. The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears to be very frequent and sequence identities of samples from cats in different districts of the island are strongly supportive of direct transmission. A near-cat-specific deletion in the domain 0 of S is present in more than 90% of cats with FIP. It is unclear as yet whether this deletion is directly associated with disease development, and it may be linked to a biotype switch12. The domain 0 deletion and several amino acid changes in S, particularly the receptor-binding domain, indicate potential changes to receptor binding and cell tropism.
- 9 July 2025
- Published by Springer Nature in Nature
- Vol. 645 (8079) , 228-234
Top Cited PapersOpen AccessFeline infectious peritonitis epizootic caused by a recombinant coronavirus
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1–3. While the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed4–7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as the susceptibility of these animals to SARS-CoV-29, highlight their importance in potential transmission cycles. While recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a highly pathogenic FCoV–CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP) originating in Cyprus11. The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears to be very frequent and sequence identities of samples from cats in different districts of the island are strongly supportive of direct transmission. A near-cat-specific deletion in the domain 0 of S is present in more than 90% of cats with FIP. It is unclear as yet whether this deletion is directly associated with disease development, and it may be linked to a biotype switch12. The domain 0 deletion and several amino acid changes in S, particularly the receptor-binding domain, indicate potential changes to receptor binding and cell tropism.
- Open Access
- 14 November 2023
- Published by Springer Nature in Research Square
Emergence and spread of feline infection peritonitis due to a highly pathogenic canine/feline recombinant coronavirus
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1-3. Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated4-7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as their susceptibility to SARS-CoV-29 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus11. The recombination, spanning spike, shows 97% sequence identity to the pantropic canine coronavirus CB/05. Infection is spreading fast and infecting cats of all ages. Development of FIP appears rapid and likely non-reliant on biotype switch12. High sequence identity of isolates from cats in different districts of the island is strongly supportive of direct transmission. A deletion and several amino acid changes in spike, particularly the receptor binding domain, compared to other FCoV-2s, indicate changes to receptor binding and likely cell tropism.
- 14 November 2023
- Published by Springer Nature in Research Square
Open AccessEmergence and spread of feline infection peritonitis due to a highly pathogenic canine/feline recombinant coronavirus
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1-3. Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated4-7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as their susceptibility to SARS-CoV-29 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus11. The recombination, spanning spike, shows 97% sequence identity to the pantropic canine coronavirus CB/05. Infection is spreading fast and infecting cats of all ages. Development of FIP appears rapid and likely non-reliant on biotype switch12. High sequence identity of isolates from cats in different districts of the island is strongly supportive of direct transmission. A deletion and several amino acid changes in spike, particularly the receptor binding domain, compared to other FCoV-2s, indicate changes to receptor binding and likely cell tropism.
- Open Access
Emergence and spread of feline infectious peritonitis due to a highly pathogenic canine/feline recombinant coronavirus
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health 1–3 . Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated 4–7 . Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E 5,8 , as well as their susceptibility to SARS-CoV-2 9 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described 5,10 , here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus 11 . The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears very frequent and sequence identities of samples from cats in different districts of the island is strongly supportive of direct transmission. A near cat-specific deletion in the domain 0 of S is present in >90% of FIP cats. It is unclear as yet whether this deletion is directly associated with disease development and may be linked to a biotype switch 12 . The domain 0 deletion and several amino acid changes in S, particularly the receptor binding domain, indicate potential changes to receptor binding and cell tropism.
Open AccessEmergence and spread of feline infectious peritonitis due to a highly pathogenic canine/feline recombinant coronavirus
Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health 1–3 . Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated 4–7 . Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E 5,8 , as well as their susceptibility to SARS-CoV-2 9 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described 5,10 , here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus 11 . The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears very frequent and sequence identities of samples from cats in different districts of the island is strongly supportive of direct transmission. A near cat-specific deletion in the domain 0 of S is present in >90% of FIP cats. It is unclear as yet whether this deletion is directly associated with disease development and may be linked to a biotype switch 12 . The domain 0 deletion and several amino acid changes in S, particularly the receptor binding domain, indicate potential changes to receptor binding and cell tropism.